
ABPI Chief Executive Mike Thompson to retire by the end of 2019
pharmafile | July 5, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | ABPI, Mike Thompson, pharma
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from his role by the end of this year.
His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.
Prior to this move, he served at major UK pharma firm GlaxoSmithKline as Seniuor Vice President of Global Commercial Strategy, the final role of a tenure last 20 years. During that time, he also serve as Commercial Strategy Head for Europe and a decade shouldering a range of senior sales and marketing positions in the UK Operating Company.
“This has been an extraordinary period to have had led the ABPI. Whilst the media has focussed on the challenges the country has faced, we can be proud of how we’ve used the dynamic to bring about positive change,” commented Thompson. “There is a lot more to say, particularly about the great people I’ve loved working with, but there will be time for that at the end of the year. I am making this announcement now so that there can be an open, and timely process to find my successor.”
The association announced that it would be recruiting for a replacement.
Matt Fellows
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …






